Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 364,299 | 178,273 | 174,422 | 125,736 | 54,004 |
| Marketable Securities | N/A | N/A | N/A | 95,680 | 251,212 |
| Receivables | 122,351 | 117,246 | 80,950 | 82,157 | 64,854 |
| Inventories | N/A | 648 | N/A | 735 | 1,081 |
| Other current assets | 0 | 0 | 847 | 0 | 0 |
| TOTAL | $495,839 | $306,852 | $266,435 | $311,596 | $380,181 |
| Non-Current Assets | |||||
| PPE Net | 8,929 | 12,429 | 7,652 | 17,274 | 20,512 |
| Intangibles | 0 | 0 | 785 | 160,690 | 166,904 |
| Other Non-Current Assets | 54,470 | 83,467 | 57,178 | 116,114 | 142,224 |
| TOTAL | $63,399 | $95,896 | $65,615 | $294,078 | $329,640 |
| Total Assets | $559,238 | $402,748 | $332,050 | $605,674 | $709,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 47,554 | N/A | N/A |
| Accounts payable and accrued liabilities | 661 | 5,487 | 14,891 | 15,958 | 17,703 |
| Accrued Expenses | 28,384 | 33,421 | 40,964 | 45,550 | 45,238 |
| Other current liabilities | N/A | N/A | 51 | 247 | 14,244 |
| TOTAL | $32,173 | $40,929 | $119,524 | $66,027 | $91,131 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 100,537 | 146,898 | 132,249 |
| Deferred Revenues | N/A | 875 | 252 | 195 | 7,719 |
| Other Non-Current Liabilities | 464,425 | 455,070 | 301,894 | 377,452 | 419,086 |
| TOTAL | $464,425 | $455,070 | $408,897 | $529,799 | $551,974 |
| Total Liabilities | $496,598 | $495,999 | $528,421 | $595,826 | $643,105 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,962 | 158,207 | 154,645 | 151,869 | 147,854 |
| Common Shares | 161 | 158 | 154 | 151 | 148 |
| Retained earnings | -1,466,056 | -1,572,232 | -1,591,128 | -1,308,760 | -1,191,823 |
| Other shareholders' equity | 0 | 0 | 0 | -79 | -7 |
| TOTAL | $62,640 | $-93,251 | $-196,371 | $9,848 | $66,716 |
| Total Liabilities And Equity | $559,238 | $402,748 | $332,050 | $605,674 | $709,821 |